Julia Aijun Wang
CIK 1860279 · Chief Financial Officer, EVP · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$675.6K
Companies
2
Total Filings
29
Lifetime Open-Market Net
-$1.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LH | Chief Financial Officer, EVP | 2,062 | $327.61 | $675.6K | $0 | 6 | 2026-02-13 |
| BeOne Medicines Ltd. (BGNE) Delisted | Chief Financial Officer | 0 | $184.71 | $0 | -$1.00M | 15 | 2024-07-03 |
Recent Filings · Page 3 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-20 | — | Notice (144) | −190 | -$36.6K | EDGAR |
| 2023-06-20 | BeOne Medicines Ltd. (BGNE) Delisted | Mixed | +107,580 | -$36.6K | EDGAR |
| 2023-03-03 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −343 | -$82.4K | EDGAR |
| 2022-07-18 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −317 | -$50.2K | EDGAR |
| 2022-07-05 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −295 | -$46.8K | EDGAR |
| 2022-06-24 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +104,377 | $0 | EDGAR |
| 2022-06-21 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −161 | -$22.0K | EDGAR |
| 2022-03-02 | BeOne Medicines Ltd. (BGNE) Delisted | Grant (A) | +61,750 | $0 | EDGAR |
| 2021-07-01 | BeOne Medicines Ltd. (BGNE) Delisted | Sell (S) | −308 | -$107.5K | EDGAR |
Showing 21–29 of 29
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.